Monoclonal antibody with unique binding to P. gingivalis toxin/survival complex KB-001 has already been shown in its first clinical study to prevent long term recolonization, thereby eliminating all of the virulence factors of P.g. contributing to systemic/organ-based inflammation at their source.

Posted in Developments